SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/79B38A7064CF041845F6B44A114155A07822A40B12D89CE3669D80B20A4DE4674AA53472D51B9AB0B161C3CA81F7D066>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/79B38A7064CF041845F6B44A114155A07822A40B12D89CE3669D80B20A4DE4674AA53472D51B9AB0B161C3CA81F7D066
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/79B38A7064CF041845F6B44A114155A07822A40B12D89CE3669D80B20A4DE4674AA53472D51B9AB0B161C3CA81F7D066
http://www.w3.org/2000/01/rdf-schema#comment
"the study identifies mutations in KRAS and POT1 as novel determinants of outcome after chemoimmunotherapy using chlorambucil and anti-CD20 treatment."
xsd:string
http://purl.uniprot.org/uniprot/#_0895372C7EE30D918941029A41643502AFCAE6A2CF46FA0567342898AF3A47E96A835222AB3DA1C69A4E5643B2220EFC
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/79B38A7064CF041845F6B44A114155A07822A40B12D89CE3669D80B20A4DE4674AA53472D51B9AB0B161C3CA81F7D066
http://purl.uniprot.org/uniprot/Q5MJ33
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/79B38A7064CF041845F6B44A114155A07822A40B12D89CE3669D80B20A4DE4674AA53472D51B9AB0B161C3CA81F7D066
http://purl.uniprot.org/uniprot/#_Q5MJ33-mappedCitation-27226433
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/79B38A7064CF041845F6B44A114155A07822A40B12D89CE3669D80B20A4DE4674AA53472D51B9AB0B161C3CA81F7D066